US FDA consults on ways to promote more electronic submissions of study data
This article was originally published in Clinica
Executive Summary
The US FDA is seeking feedback on a draft guidance designed to encourage drug and medical device companies to submit nonclinical and clinical study data to the agency in a standardised electronic format.